Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SIPI CLINIC LLC

NPI: 1780398586 · TWIN FALLS, ID 83301 · Clinic/Center · NPI assigned 01/06/2023

$299K
Total Medicaid Paid
5,348
Total Claims
5,061
Beneficiaries
6
Codes Billed
2020-06
First Month
2024-12
Last Month

Provider Details

Authorized OfficialRUE, DENISE (OFFICE MANAGER)
NPI Enumeration Date01/06/2023

Related Entities

Other providers sharing the same authorized official: RUE, DENISE

ProviderCityStateTotal Paid
SIPI AMBULATORY SURGERY CENTER TWIN FALLS ID $15K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 101 $952.22
2021 280 $8K
2022 309 $6K
2023 2,553 $149K
2024 2,105 $135K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,282 3,056 $196K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 564 551 $58K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 386 372 $22K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 386 372 $12K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 112 107 $6K
80305 618 603 $5K